BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torsetnes SB, Nordlund MS, Paus E, Halvorsen TG, Reubsaet L. Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms. J Proteome Res 2013;12:412-20. [PMID: 23190087 DOI: 10.1021/pr300751j] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Torsetnes SB, Levernæs MS, Broughton MN, Paus E, Halvorsen TG, Reubsaet L. Multiplexing Determination of Small Cell Lung Cancer Biomarkers and Their Isovariants in Serum by Immunocapture LC-MS/MS. Anal Chem 2014;86:6983-92. [DOI: 10.1021/ac500986t] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
2 Levernæs MCS, Farhat B, Oulie I, Abdullah SS, Paus E, Reubsaet L, Halvorsen TG. Immunocapture sample clean-up in determination of low abundant protein biomarkers – a feasibility study of peptide capture by anti-protein antibodies. RSC Adv 2019;9:34902-11. [DOI: 10.1039/c9ra05071j] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Torsetnes SB, Løvbak SG, Claus C, Lund H, Nordlund MS, Paus E, Halvorsen TG, Reubsaet L. Immunocapture and LC–MS/MS for selective quantification and differentiation of the isozymes of the biomarker neuron-specific enolase in serum. Journal of Chromatography B 2013;929:125-32. [DOI: 10.1016/j.jchromb.2013.04.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
4 Viodé A, Fournier C, Camuzat A, Fenaille F, Latouche M, Elahi F, Le Ber I, Junot C, Lamari F, Anquetil V, Becher F; NeuroCEB Brain Bank. New Antibody-Free Mass Spectrometry-Based Quantification Reveals That C9ORF72 Long Protein Isoform Is Reduced in the Frontal Cortex of Hexanucleotide-Repeat Expansion Carriers. Front Neurosci 2018;12:589. [PMID: 30210275 DOI: 10.3389/fnins.2018.00589] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
5 Levernæs MCS, Brandtzaeg OK, Amundsen SF, Reubsaet L, Lundanes E, Halvorsen TG, Wilson SR. Selective Fishing for Peptides with Antibody-Immobilized Acrylate Monoliths, Coupled Online with NanoLC-MS. Anal Chem 2018;90:13860-6. [DOI: 10.1021/acs.analchem.8b00935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
6 Rossetti C, Abdel Qader A, Halvorsen TG, Sellergren B, Reubsaet L. Antibody-Free Biomarker Determination: Exploring Molecularly Imprinted Polymers for Pro-Gastrin Releasing Peptide. Anal Chem 2014;86:12291-8. [DOI: 10.1021/ac503559c] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
7 Rossetti C, Levernæs MC, Reubsaet L, Halvorsen TG. Evaluation of affinity-based serum clean-up in mass spectrometric analysis: Plastic vs monoclonal antibodies. Journal of Chromatography A 2016;1471:19-26. [DOI: 10.1016/j.chroma.2016.09.069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
8 Levernæs MCS, Moe AU, Bøe SL, Paus E, Reubsaet L, Halvorsen TG. Liquid chromatography mass spectrometry based characterization of epitope configurations. Anal Methods 2020;12:5476-84. [PMID: 33141131 DOI: 10.1039/d0ay01283a] [Reference Citation Analysis]
9 Skjærvø Ø, Trimpin S, Halvorsen TG. Matrix‐assisted ionization mass spectrometry in targeted protein analysis – An initial evaluation. Rapid Commun Mass Spectrom 2021;35. [DOI: 10.1002/rcm.8437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Levernæs MCS, Broughton MN, Reubsaet L, Halvorsen TG. To elute or not to elute in immunocapture bottom-up LC–MS. Journal of Chromatography B 2017;1055-1056:51-60. [DOI: 10.1016/j.jchromb.2017.03.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
11 Halvorsen TG, Levernæs MCS, Rosting C. Matrix-Assisted Ionization and Tandem Mass Spectrometry Capabilities in Protein Biomarker Characterization-An Initial Study Using the Small Cell Lung Cancer Biomarker Progastrin Releasing Peptide as a Model Compound. J Am Soc Mass Spectrom 2021;32:611-4. [PMID: 33382608 DOI: 10.1021/jasms.0c00336] [Reference Citation Analysis]
12 Hustoft HK, Brandtzaeg OK, Rogeberg M, Misaghian D, Torsetnes SB, Greibrokk T, Reubsaet L, Wilson SR, Lundanes E. Integrated enzyme reactor and high resolving chromatography in "sub-chip" dimensions for sensitive protein mass spectrometry. Sci Rep 2013;3:3511. [PMID: 24336509 DOI: 10.1038/srep03511] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
13 Kuner R. Lung Cancer Gene Signatures and Clinical Perspectives. Microarrays (Basel) 2013;2:318-39. [PMID: 27605195 DOI: 10.3390/microarrays2040318] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fredolini C, Byström S, Pin E, Edfors F, Tamburro D, Iglesias MJ, Häggmark A, Hong MG, Uhlen M, Nilsson P, Schwenk JM. Immunocapture strategies in translational proteomics. Expert Rev Proteomics 2016;13:83-98. [PMID: 26558424 DOI: 10.1586/14789450.2016.1111141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
15 Gianazza E, Tremoli E, Banfi C. The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases. Expert Rev Proteomics 2014;11:771-88. [PMID: 25400095 DOI: 10.1586/14789450.2014.947966] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
16 McKitterick N, Braathen F, Switnicka-Plak MA, Cormack PAG, Reubsaet L, Halvorsen TG. Magnetic Synthetic Receptors for Selective Clean-Up in Protein Biomarker Quantification. J Proteome Res 2020;19:3573-82. [PMID: 32614597 DOI: 10.1021/acs.jproteome.0c00258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
17 Dai Z, Zhu J, Huang H, Fang L, Lin Y, Huang S, Xie F, Sheng N, Liang X. Expression and clinical value of gastrin‐releasing peptide precursor in nephropathy and chronic kidney disease. Nephrology 2020;25:398-405. [DOI: 10.1111/nep.13642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rossetti C, Świtnicka-Plak MA, Grønhaug Halvorsen T, Cormack PA, Sellergren B, Reubsaet L. Automated Protein Biomarker Analysis: on-line extraction of clinical samples by Molecularly Imprinted Polymers. Sci Rep 2017;7:44298. [PMID: 28303910 DOI: 10.1038/srep44298] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
19 Qader AA, Urraca J, Torsetnes SB, Tønnesen F, Reubsaet L, Sellergren B. Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide. Journal of Chromatography A 2014;1370:56-62. [DOI: 10.1016/j.chroma.2014.10.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
20 Viglio S, Stolk J, Iadarola P, Giuliano S, Luisetti M, Salvini R, Fumagalli M, Bardoni A. Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013. Proteomes 2014;2:18-52. [PMID: 28250368 DOI: 10.3390/proteomes2010018] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 van den Broek I, Niessen WM, van Dongen WD. Bioanalytical LC–MS/MS of protein-based biopharmaceuticals. Journal of Chromatography B 2013;929:161-79. [DOI: 10.1016/j.jchromb.2013.04.030] [Cited by in Crossref: 171] [Cited by in F6Publishing: 137] [Article Influence: 19.0] [Reference Citation Analysis]
22 Chambers AG, Percy AJ, Simon R, Borchers CH. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum. Expert Rev Proteomics 2014;11:137-48. [PMID: 24476379 DOI: 10.1586/14789450.2014.877346] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
23 Zhao Y, Liu G, Kwok S, Jones BR, Liu J, Marchisin D, Joyce PE, Peterson J, Shen JX. Highly selective and sensitive measurement of active forms of FGF21 using novel immunocapture enrichment with LC–MS/MS. Bioanalysis 2018;10:23-33. [DOI: 10.4155/bio-2017-0208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Torsetnes SB, Broughton MN, Paus E, Halvorsen TG, Reubsaet L. Determining ProGRP and isoforms in lung and thyroid cancer patient samples: comparing an MS method with a routine clinical immunoassay. Anal Bioanal Chem 2014;406:2733-8. [PMID: 24518900 DOI: 10.1007/s00216-014-7634-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
25 Boysen RI. Advances in the development of molecularly imprinted polymers for the separation and analysis of proteins with liquid chromatography. J Sep Sci 2019;42:51-71. [PMID: 30411488 DOI: 10.1002/jssc.201800945] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
26 Moody TW, Moreno P, Jensen RT. Neuropeptides as lung cancer growth factors. Peptides 2015;72:106-11. [PMID: 25836991 DOI: 10.1016/j.peptides.2015.03.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]